|
Diverse Asthma Treatment Pipeline Presents Major Investment Opportunity, says …
Drug Discovery & Development The company's latest report* states that while asthma therapy development is dominated by small molecule compounds, with 156 products representing 67% of the pipeline, the research and development landscape has moved towards biologics on an … |
View full post on asthma – Google News